DrugPatentWatch Database Preview

CLINDAGEL Drug Profile

« Back to Dashboard

When do Clindagel patents expire, and what generic alternatives are available?

Clindagel is a drug marketed by Precision Dermat and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-two countries.

The generic ingredient in CLINDAGEL is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for CLINDAGEL

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	37
Clinical Trials:	1
Patent Applications:	1,173
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CLINDAGEL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CLINDAGEL
DailyMed Link:	CLINDAGEL at DailyMed

Pharmacology for CLINDAGEL

Drug Class	Lincosamide Antibacterial
Physiological Effect	Decreased Sebaceous Gland Activity

Synonyms for CLINDAGEL

(2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate)

[(2R,3R,4S,5R,6R)-6-(2-CHLORO-1-{[(2S,4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL]FORMAMIDO}PROPYL)-4,5-DIHYDROXY-2-(METHYLSULFANYL)OXAN-3-YL]OXYPHOSPHONIC ACID

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxyphosphonic acid

[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate

[6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate

[6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate

24729-96-2

6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)carbonylamino]propyl}-4,5-dih ydroxy-2-methylthio(2H-3,4,5,6-tetrahydropyran-3-yl) dihydrogen phosphate

7(S)-Chloro-7-deoxylincomycin 2-phosphate

AB01566857_01

AC-11380

AC1L1O0X

AC1L7D1S

AC1L9EKE

AK163189

AKOS008901431

AKOS015894857

AKOS015960484

AKOS026750036

AN-7052

API0002056

AS-12554

AX8019646

BDBM241975

C11728

C18H34ClN2O8PS

CA008882

CAS-24729-96-2

CHEBI:3746

CHEMBL3184512

Cleocin phosphate

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Cleocin T

Clinda-Derm

Clindamycin (phosphate)

Clindamycin 2-dihydrogen phosphate

Clindamycin 2-phosphate

Clindamycin dihydrogenphosphat

Clindamycin phosphate

Clindamycin phosphate (JP16/USP)

Clindamycin phosphate (JP17/USP)

Clindamycin phosphate [USAN:JAN]

Clindamycin phosphate [USAN:USP:JAN]

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Clindamycin-2-dihydrogenphosphat

CLINDAMYCIN-2-PHOSPHATE

Clindets

CS-4620

D01073

Dalacin P

Dalacin T

Dalacin-S (TN)

DR003082

DSSTox_CID_28603

DSSTox_GSID_48677

DSSTox_RID_82873

DTXSID1048677

EH6D7113I8

EINECS 246-433-0

Evoclin (TN)

HY-B1064

I06-0114

KS-00000XNT

L-threo-.alpha.-D-galacto-Octopyranoside,7,8-trideoxy-6-[[(1-methyl-4-propyl-2- pyrrolidinyl)carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-

L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-

L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-

LS-98133

Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate)

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)

methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-O-phosphono-1-thiooctopyranoside

MFCD07793328

MFCD11982855

MolPort-006-666-188

MolPort-015-163-859

NCGC00163494-01

NCGC00166320-01

NSC-618653

NSC618653

PubChem5913

s2048

SBB071022

SCHEMBL37148

SCHEMBL718004

SR-01000872581

SR-01000872581-1

ST075182

ST24046358

SureCN718004

Tox21_113055

Tox21_113410

U 28508

U-28,508

U-28508

UFUVLHLTWXBHGZ-MGZQPHGTSA-N

UNII-EH6D7113I8

ZINC4102185

US Patents and Regulatory Information for CLINDAGEL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Precision Dermat	CLINDAGEL	clindamycin phosphate	GEL;TOPICAL	050782-001	Nov 27, 2000	BT	RX	Yes	Yes			Y

International Patents for CLINDAGEL

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	0211683
Poland	360589
South Korea	100840169

Supplementary Protection Certificates for CLINDAGEL

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
401	Luxembourg		PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
90049-3	Sweden		PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
2013025,C1304992	Lithuania		PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323